Literature DB >> 28947934

New Substituted Cyanoindoline Derivatives as MAP3K14 Kinase Inhibitors for the Treatment of Cancer and Autoimmune Disorders.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2017        PMID: 28947934      PMCID: PMC5601364          DOI: 10.1021/acsmedchemlett.7b00330

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  1 in total

1.  Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K).

Authors:  Georgette M Castanedo; Nicole Blaquiere; Maureen Beresini; Brandon Bravo; Hans Brightbill; Jacob Chen; Hai-Feng Cui; Charles Eigenbrot; Christine Everett; Jianwen Feng; Robert Godemann; Emily Gogol; Sarah Hymowitz; Adam Johnson; Nobuhiko Kayagaki; Pawan Bir Kohli; Kathleen Knüppel; Joachim Kraemer; Susan Krüger; Pui Loke; Paul McEwan; Christian Montalbetti; David A Roberts; Myron Smith; Stefan Steinbacher; Swathi Sujatha-Bhaskar; Ryan Takahashi; Xiaolu Wang; Lawren C Wu; Yamin Zhang; Steven T Staben
Journal:  J Med Chem       Date:  2017-01-12       Impact factor: 7.446

  1 in total
  1 in total

Review 1.  Small Molecule NF-κB Pathway Inhibitors in Clinic.

Authors:  Venkataramanan Ramadass; Thamilselvan Vaiyapuri; Vinay Tergaonkar
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.